Voluntary HIV testing for adults in France
Part of Immune system & allergy, Infections clinical trials.
This study offers free, voluntary HIV testing to anyone in France who is 18 or older. It aims to make HIV screening easy and accessible, regardless of your sexual history or past testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are male or female.
- You can be any sexual orientation.
- You may or may not have had an HIV test before.
- You agree to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers sexual health checkups and prevention services to women who are in difficult social or financial situations, including those without stable housing or who have sold sex for money. The goal is to see if these services are helpful and acceptable.
This study follows people starting treatment for tuberculosis (TB) in France to learn more about the disease and its treatment. If you have been diagnosed with TB and started treatment within the last 8 days, you may be able to join.
This trial offers women in Marne and Aube who are first-time invitees for cervical screening a chance to collect their own sample (HPV self-sampling) at home instead of having a doctor or nurse do it. It aims to make screening easier and more convenient.
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
This study uses a secure video-call service to make sexual health care easier for transgender sex workers and their clients. You would have a telehealth visit to get preventive services, like testing or advice.
This study looks at HIV in people who have just been diagnosed. It checks for drug resistance (whether the virus is resistant to certain medicines) and how the virus spreads, which can help doctors choose the best treatment for you and others.
Hear when a new Human Immunodeficiency Virus (HIV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.